Baseline characteristics

Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma · Source last updated 2017-04-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      26

   units

   Participants

groups

1. description

   letrozole 2.5mg by mouth per day

   id

   BG000

   title

   Letrozole

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            lower Limit

            44

            upper Limit

            74

            value

            56

   dispersion Type

   FULL_RANGE

   param Type

   MEAN

   title

   Age, Continuous

   unit Of Measure

   years

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            26

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            0

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

population Description

27 patients were enrolled, and 26 patients received at least one dose of study medication and were included in the analysis.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice